3Kylye RA. Newer approaches to the therapy of multiple myeloma.Blood, 1990, 76:1678. 被引量：1
4Trieot G, Jaginnaths, Vesole DH, et al. Hemalopoietic stem cell transplants for multiple myeloma.Leukemia Lymphoma, 1996,22:25. 被引量：1
5Alexamian R. Management of multiple myeloma. Semin Hematol,1995,32(1) :20. 被引量：1
6Sakuraya M,Tamura J, Itob K, et al. Aminopeptidase inhibitor ubenimex inhibits the growth of leukaemic cell lines and anyeloma cells through its cytotoxicity.J Int Med Res ,2000 , 28(5):214. 被引量：1
二级参考文献4
1Fuminori Abe,Akira Matsuda,Mark Schneider,James E. Talmadge. Effects of bestatin on myelopoietic stem cells in normal and cyclophosphamide-treated mice[J] 1990,Cancer Immunology Immunotherapy(2):75～80 被引量：1
2Fuminori Abe,Mark Schneider,Paul L. Black,James E. Talmadge. Chemoimmunotherapy with cyclophosphamide and bestatin in experimental metastasis in mice[J] 1989,Cancer Immunology Immunotherapy(4):231～236 被引量：1
3Henric Blomgren,Ingemar N?slund,Pier-Luigi Esposti,Lise Johansen,Ove Aaskoven. Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder[J] 1987,Cancer Immunology Immunotherapy(1):41～46 被引量：1
4Kazuo Ota,Soji Kurita,Kazumasa Yamada,Tohru Masaoka,Yoshiro Uzuka,Nobuya Ogawa. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults[J] 1986,Cancer Immunology Immunotherapy(1):5～10 被引量：1
